Murphy staging system for Burkitt lymphoma.
Notes: | |
1) Favorable disease for Magrath regimen is stage I or stage IIR AND normal LDH. | |
2) > 25% bone marrow involvement is defined as L3 ALL and is not included in this staging system. | |
Stage I: | Single nodal or extranodal site excluding mediastinum or abdomen |
Stage II: | Single extranodal tumor with regional nodal involvement Two extranodal tumors on one side of diaphragm Primary gastrointestinal tumor with or without associated mesenteric nodes Two or more nodal areas on one side of diaphragm |
Stage IIR: | Completely resected intra-abdominal disease |
Stage III: | Two single extranodal tumors on opposite sides of diaphragm All primary intrathoracic tumors All paraspinal or epidural tumors All extensive primary intra-abdominal disease Two or more nodal areas on opposite sides of diaphragm |
Stage IIIA: | Localized, non-resectable abdominal disease |
Stage IIIB: | Widespread multiorgan abdominal disease |
Stage IV: | Initial CNS or bone marrow involvement (< 25%) |
Notes: | |
1) Favorable disease for Magrath regimen is stage I or stage IIR AND normal LDH. | |
2) > 25% bone marrow involvement is defined as L3 ALL and is not included in this staging system. | |
Stage I: | Single nodal or extranodal site excluding mediastinum or abdomen |
Stage II: | Single extranodal tumor with regional nodal involvement Two extranodal tumors on one side of diaphragm Primary gastrointestinal tumor with or without associated mesenteric nodes Two or more nodal areas on one side of diaphragm |
Stage IIR: | Completely resected intra-abdominal disease |
Stage III: | Two single extranodal tumors on opposite sides of diaphragm All primary intrathoracic tumors All paraspinal or epidural tumors All extensive primary intra-abdominal disease Two or more nodal areas on opposite sides of diaphragm |
Stage IIIA: | Localized, non-resectable abdominal disease |
Stage IIIB: | Widespread multiorgan abdominal disease |
Stage IV: | Initial CNS or bone marrow involvement (< 25%) |